Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biol Psychiatry. 2007 Nov 1;62(9):1059-61. Epub 2007 May 23.

Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.

Author information

  • 1Pediatric Psychopharmacology Unit, Psychiatry Service Massachusetts General Hospital, Boston, Massachusetts, USA. tspencer@partners.org

Abstract

BACKGROUND:

The dopamine transporter (DAT) is known to be a key regulator of dopamine, and recent studies of genetics, treatment, and imaging have highlighted the role of DAT in attention-deficit/hyperactivity disorder (ADHD). The findings of in vivo neuroimaging of DAT in ADHD have been somewhat discrepant, however.

METHOD:

Dopamine transporter binding was measured using a highly selective ligand (C-11 altropane) and positron emission tomography (PET). The sample consisted of 47 well-characterized, treatment-naïve, nonsmoking, non-comorbid adults with and without ADHD. Additionally, control subjects had few symptoms of ADHD.

RESULTS:

Results showed significantly increased DAT binding in the right caudate in adults with ADHD compared with matched control subjects without this disorder.

CONCLUSIONS:

These results confirm abnormal DAT binding in the striatum of adults with ADHD and provide further support that dysregulation of DAT may be an important component of the pathophysiology of ADHD.

PMID:
17511972
[PubMed - indexed for MEDLINE]
PMCID:
PMC2715944
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk